Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Idorsia seen up after FDA breakthrough designation for pediatric insomnia drug

By Reuters News

** Shares in Swiss biopharmaceutical company Idorsia IDIA.S are seen up about 4.2% in premarket trading after the US FDA granted Breakthrough Therapy Designation to daridorexant for pediatric insomnia disorder

** The company said the designation recognizes positive clinical evidence and a significant unmet medical need, with no FDA-approved drug treatments currently available for pediatric insomnia

** Idorsia plans to start a Phase 3 study in pediatric insomnia in the second half of 2027

** Shares were up about 2% year-to-date at Tuesday's close

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.